HEADER PROTEIN BINDING/PEPTIDE 25-APR-19 6JXV TITLE SUMO1 BOUND TO PHOSPHORYLATED SLS4-SIM PEPTIDE FROM ICP0 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SMALL UBIQUITIN-RELATED MODIFIER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SUMO; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PHOSPHORYLATED SLS4-SIM FROM UBIQUITIN E3 LIGASE ICP0; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SUMO1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN ALPHAHERPESVIRUS 1 STRAIN 17; SOURCE 11 ORGANISM_TAXID: 10299 KEYWDS SUMOYLATION, PHOSPHORYLATION, PROTEIN BINDING-PEPTIDE COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR D.S.S.HEMBRAM,H.NEGI,D.SHET,R.DAS REVDAT 4 14-JUN-23 6JXV 1 REMARK REVDAT 3 27-MAY-20 6JXV 1 JRNL REVDAT 2 25-MAR-20 6JXV 1 JRNL REVDAT 1 05-FEB-20 6JXV 0 JRNL AUTH D.S.S.HEMBRAM,H.NEGI,P.BISWAS,V.TRIPATHI,L.BHUSHAN,D.SHET, JRNL AUTH 2 V.KUMAR,R.DAS JRNL TITL THE VIRAL SUMO-TARGETED UBIQUITIN LIGASE ICP0 IS JRNL TITL 2 PHOSPHORYLATED AND ACTIVATED BY HOST KINASE CHK2. JRNL REF J.MOL.BIOL. V. 432 1952 2020 JRNL REFN ESSN 1089-8638 JRNL PMID 32001251 JRNL DOI 10.1016/J.JMB.2020.01.021 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : HADDOCK REMARK 3 AUTHORS : BONVIN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JXV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-APR-19. REMARK 100 THE DEPOSITION ID IS D_1300007346. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 137 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.7 MM [U-13C; U-15N] SUMO1, 1.2 REMARK 210 MM PHOSPHORYLATED SLS4, 90% H2O/ REMARK 210 10% D2O; 0.5 MM [U-15N] SUMO1, REMARK 210 2.0 MM PHOSPHORYLATED SLS4, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HALF-FILTERED REMARK 210 NOESY; 3D HNCO; 3D HNCA; 3D HCCH- REMARK 210 TOCSY; 3D HN(CO)CA; 3D CBCA(CO)NH REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ASP A 3 REMARK 465 GLN A 4 REMARK 465 GLU A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 PRO A 8 REMARK 465 SER A 9 REMARK 465 THR A 10 REMARK 465 GLU A 11 REMARK 465 ASP A 12 REMARK 465 LEU A 13 REMARK 465 GLY A 14 REMARK 465 ASP A 15 REMARK 465 LYS A 16 REMARK 465 LYS A 17 REMARK 465 GLU A 18 REMARK 465 GLY A 19 REMARK 465 GLU A 20 REMARK 465 HIS A 98 REMARK 465 SER A 99 REMARK 465 THR A 100 REMARK 465 VAL A 101 REMARK 465 LEU B 355 REMARK 465 ALA B 356 REMARK 465 PRO B 369 REMARK 465 ALA B 370 REMARK 465 SER B 371 REMARK 465 PRO B 372 REMARK 465 HIS B 373 REMARK 465 ARG B 374 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ2 LYS A 23 OE1 GLU A 85 1.56 REMARK 500 HZ1 LYS A 48 OD1 ASP A 73 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 41 -40.14 -161.42 REMARK 500 1 ASN A 60 -0.27 79.78 REMARK 500 1 LEU A 80 -55.90 72.26 REMARK 500 2 THR A 41 -24.86 170.39 REMARK 500 2 LEU A 80 -53.04 73.06 REMARK 500 3 THR A 41 -32.61 174.67 REMARK 500 3 LEU A 80 -56.59 72.89 REMARK 500 4 ASP A 30 40.60 -104.96 REMARK 500 4 THR A 41 -24.91 169.82 REMARK 500 4 LEU A 80 -49.00 73.26 REMARK 500 5 SER A 31 66.42 61.00 REMARK 500 5 THR A 41 -26.33 174.09 REMARK 500 5 ASN A 60 -7.38 76.65 REMARK 500 5 LEU A 80 -46.56 73.45 REMARK 500 6 THR A 41 -26.16 175.95 REMARK 500 6 ASN A 60 -3.59 77.35 REMARK 500 6 LEU A 80 -62.76 71.21 REMARK 500 7 THR A 41 -29.85 173.87 REMARK 500 7 ASN A 60 -8.50 79.06 REMARK 500 7 LEU A 80 -59.15 72.34 REMARK 500 8 THR A 41 -46.81 -164.04 REMARK 500 8 LEU A 80 -54.62 72.94 REMARK 500 9 THR A 41 -35.54 173.68 REMARK 500 9 ASN A 60 -3.57 79.13 REMARK 500 9 LEU A 80 -42.39 73.78 REMARK 500 10 SER A 31 39.58 71.22 REMARK 500 10 THR A 41 -29.96 171.86 REMARK 500 10 LEU A 80 -60.06 73.78 REMARK 500 11 THR A 41 -38.19 -163.15 REMARK 500 11 ASN A 60 -16.90 79.70 REMARK 500 11 LEU A 80 -46.96 73.01 REMARK 500 12 THR A 41 -30.20 173.13 REMARK 500 12 LEU A 80 -58.49 72.17 REMARK 500 13 THR A 41 -42.11 -158.07 REMARK 500 13 ASN A 60 6.11 83.62 REMARK 500 13 LEU A 80 -41.38 73.84 REMARK 500 14 THR A 41 -25.83 170.12 REMARK 500 14 LEU A 80 -48.81 73.01 REMARK 500 15 THR A 41 -37.41 177.95 REMARK 500 15 LEU A 80 -59.46 73.04 REMARK 500 16 THR A 41 -38.76 -161.69 REMARK 500 16 ASN A 60 -3.78 82.53 REMARK 500 16 LEU A 80 -51.36 73.79 REMARK 500 17 THR A 41 -45.15 -154.64 REMARK 500 17 ASN A 60 -0.48 81.03 REMARK 500 17 LEU A 80 -43.65 73.69 REMARK 500 18 THR A 41 -41.80 -176.92 REMARK 500 18 ASN A 60 -5.88 79.06 REMARK 500 18 LEU A 80 -49.79 72.63 REMARK 500 19 THR A 41 -30.96 178.25 REMARK 500 REMARK 500 THIS ENTRY HAS 53 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 36031 RELATED DB: BMRB DBREF1 6JXV A 1 101 UNP A0A024R3Z2_HUMAN DBREF2 6JXV A A0A024R3Z2 1 101 DBREF 6JXV B 355 374 PDB 6JXV 6JXV 355 374 SEQRES 1 A 101 MET SER ASP GLN GLU ALA LYS PRO SER THR GLU ASP LEU SEQRES 2 A 101 GLY ASP LYS LYS GLU GLY GLU TYR ILE LYS LEU LYS VAL SEQRES 3 A 101 ILE GLY GLN ASP SER SER GLU ILE HIS PHE LYS VAL LYS SEQRES 4 A 101 MET THR THR HIS LEU LYS LYS LEU LYS GLU SER TYR CYS SEQRES 5 A 101 GLN ARG GLN GLY VAL PRO MET ASN SER LEU ARG PHE LEU SEQRES 6 A 101 PHE GLU GLY GLN ARG ILE ALA ASP ASN HIS THR PRO LYS SEQRES 7 A 101 GLU LEU GLY MET GLU GLU GLU ASP VAL ILE GLU VAL TYR SEQRES 8 A 101 GLN GLU GLN THR GLY GLY HIS SER THR VAL SEQRES 1 B 20 LEU ALA ASN ASN ARG ASP PRO ILE VAL ILE SEP ASP SEP SEQRES 2 B 20 PRO PRO ALA SER PRO HIS ARG HET SEP B 365 14 HET SEP B 367 14 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP 2(C3 H8 N O6 P) HELIX 1 AA1 HIS A 43 GLY A 56 1 14 SHEET 1 AA1 6 GLN A 69 ARG A 70 0 SHEET 2 AA1 6 LEU A 62 PHE A 66 -1 N PHE A 66 O GLN A 69 SHEET 3 AA1 6 VAL A 87 GLN A 92 -1 O TYR A 91 N ARG A 63 SHEET 4 AA1 6 ILE A 22 ILE A 27 1 N LYS A 25 O ILE A 88 SHEET 5 AA1 6 GLU A 33 VAL A 38 -1 O VAL A 38 N ILE A 22 SHEET 6 AA1 6 ARG B 359 VAL B 363 1 O ASP B 360 N HIS A 35 LINK C ILE B 364 N SEP B 365 1555 1555 1.32 LINK C SEP B 365 N ASP B 366 1555 1555 1.32 LINK C ASP B 366 N SEP B 367 1555 1555 1.32 LINK C SEP B 367 N PRO B 368 1555 1555 1.34 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1